Korean J Gastroenterol.  2014 Apr;63(4):262-264. 10.4166/kjg.2014.63.4.262.

Is Chemoprevention of Pancreatic Cancer Possible by Aspirin Consumption?

• Kim YS
• Choi YW

• KMID: 1791886
• DOI: http://doi.org/10.4166/kjg.2014.63.4.262

Abstract

No abstract available.

Reference

References

1. Cui XJ, He Q, Zhang JM, Fan HJ, Wen ZF, Qin YR. High-dose aspirin consumption contributes to decreased risk for pancreatic cancer in a systematic review and metaanalysis. Pancreas. 2014; 43:135–140.

2. 2011 National cancer registration and statistics. [Internet]. Goyang: Korea Central Cancer Registry [cited 2013 Dec 26]. Available from:. https://ncrs.cancer.go.kr/index.do.

3. Flossmann E, Rothwell PM. British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007; 369:1603–1613.

4. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011; 377:31–41.

5. Tian W, Zhao Y, Liu S, Li X. Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev. 2010; 19:288–298.

6. Wang MT, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev. 2007; 26:525–534.

7. Kim SR, Bae MK, Kim JY, Wee HJ, Yoo MA, Bae SK. Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Biochem Biophys Res Commun. 2009; 387:342–347.

8. Sclabas GM, Uwagawa T, Schmidt C, et al. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. Cancer. 2005; 103:2485–2490.

9. Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: metaanalysis of the randomized trials. J Natl Cancer Inst. 2009; 101:256–266.

10. Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012; 23:1403–1415.

11. Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005; 294:47–55.

12. Anderson KE, Johnson TW, Lazovich D, Folsom AR. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst. 2002; 94:1168–1171.

13. Larsson SC, Giovannucci E, Bergkvist L, Wolk A. Aspirin and non-steroidal anti-inflammatory drug use and risk of pancreatic cancer: a metaanalysis. Cancer Epidemiol Biomarkers Prev. 2006; 15:2561–2564.

14. Capurso G, Schünemann HJ, Terrenato I, et al. Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories. Aliment Pharmacol Ther. 2007; 26:1089–1099.